# Thomas Klein

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/thomas-klein/

## Facts

| Field | Value |
| --- | --- |
| Citations | 20,708 |
| Field | Diabetes Treatment and Management |
| h-index | 73 |
| i10-index | 336 |
| Last Known Institution | Boehringer Ingelheim (Germany) |
| OpenAlex ID | https://openalex.org/A5032965517 |
| ORCID iD | https://orcid.org/0000-0001-5762-9166 |
| Works | 722 |

## Researcher topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Legionella and Acanthamoeba research](https://scholariq.org/topics/legionella-and-acanthamoeba-research/)
- [Cannabis and Cannabinoid Research](https://scholariq.org/topics/cannabis-and-cannabinoid-research/)
- [Neutrophil, Myeloperoxidase and Oxidative Mechanisms](https://scholariq.org/topics/neutrophil-myeloperoxidase-and-oxidative-mechanisms/)
- [Immune Cell Function and Interaction](https://scholariq.org/topics/immune-cell-function-and-interaction/)

## Researcher university

- [Boehringer Ingelheim (Germany)](https://scholariq.org/institutions/boehringer-ingelheim-germany/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.